TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect health.
Peck-Radosavljevic
Markus
M
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000145:classification / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000592:standards; D018572:Disease-Free Survival; D016503:Drug Delivery Systems; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D008863:Microspheres; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000970:Antineoplastic Agents